Syndax Pharmaceuticals Balance Sheet (2015-2026) | SNDX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	68.16M	71.55M	222.08M	188.89M	120.24M	71.38M	74.36M	57.52M	97.28M	94.55M	295.39M	114.61M	105.40M	133.02M	154.08M	153.99M	108.64M	116.81M	134.93M	130.89M
Short-term Investments (Quarter)	6.92M	158.28M	0.12M	12.98M	9.89M	12.87M	0.12M	5.81M	7.22M	10.27M	275.30M	319.96M	7.17M	256.59M	418.80M	4.12M	346.60M	319.17M	19.62M	9.18M
Cash & Current Investments (Quarter)	75.07M	229.83M	222.19M	201.87M	130.13M	84.25M	74.47M	63.33M	104.50M	104.81M	570.70M	434.58M	112.57M	389.61M	572.88M	158.11M	455.23M	435.98M	154.55M	140.07M
Receivables - Net (Quarter)															7.60M	15.72M	19.45M	25.40M	38.00M	38.12M
Receivables - Other (Quarter)	0.43M	0.18M	0.43M	0.16M	13.10M	4.54M	0.58M	0.68M	0.53M	3.41M	1.23M	1.51M	2.00M	1.70M	3.63M	10.30M	16.60M	20.90M	28.10M	24.70M
Receivables (Quarter)											1.23M				11.24M	26.02M	36.05M	46.30M	66.10M	62.82M
Raw Materials (Quarter)																1.74M	14.18M	21.40M	29.03M	30.70M
Work In Process (Quarter)															0.33M	0.57M	1.27M	1.38M	2.11M	2.87M
Finished Goods (Quarter)															0.04M	2.35M	2.25M	2.22M	1.61M	1.38M
Inventory (Quarter)	0.02M														0.37M	4.66M	17.70M	25.00M	32.75M	34.95M
Prepaid Assets (Quarter)	9.31M	0.24M	0.64M	2.15M	1.56M	0.15M	0.69M	0.17M	1.46M	1.34M	0.16M	6.07M	4.21M	3.51M	1.28M	0.04M	1.47M	9.52M	13.50M	0.05M
Current Assets (Quarter)	262.56M	238.25M	448.40M	420.06M	392.29M	357.63M	489.79M	441.51M	409.08M	380.97M	580.88M	453.90M	446.06M	414.81M	603.06M	548.75M	531.68M	529.83M	528.08M	471.18M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)	0.17M	0.16M	0.28M	0.27M	0.26M	0.02M	0.02M	0.02M	0.01M	0.01M	0.01M	0.01M	0.00M					0.13M	0.18M	0.18M
Long-Term Investments (Quarter)					12.12M		5.47M	16.56M	19.48M	15.71M	29.83M	87.42M	29.52M	10.03M	119.52M	89.94M	62.63M	20.15M
Long-Term Deferred Tax (Quarter)							48.90M				53.70M
Other Non-Current Assets (Quarter)	0.12M	0.12M		0.12M	0.12M	0.12M	0.12M	0.12M	0.58M	0.22M	0.22M	0.25M	0.16M		0.22M	0.22M	0.22M	0.22M	0.10M	0.10M
Non-Current Assets (Quarter)	0.50M	1.25M	1.26M	2.17M	14.15M	2.06M	7.45M	18.32M	22.26M	18.25M	32.00M	89.13M	30.89M	11.00M	121.76M	91.96M	64.47M	21.96M	1.62M	1.49M
Assets (Quarter)	263.06M	239.50M	449.66M	422.22M	406.44M	359.69M	497.24M	459.83M	431.34M	399.22M	612.88M	543.03M	476.95M	425.81M	724.82M	640.71M	596.15M	551.79M	529.71M	472.67M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	3.62M	5.12M	5.67M	8.23M	6.44M	7.12M	4.35M	8.06M	10.98M	6.05M	9.96M	8.81M	11.57M	4.90M	11.63M	10.05M	17.35M	13.83M	16.58M	10.84M
Payables (Quarter)	3.62M	5.12M	5.67M	8.23M	6.44M	7.12M	4.35M	8.06M	10.98M	6.05M	9.96M	8.81M	11.57M	4.90M	11.63M	10.05M	17.35M	13.83M	16.58M	10.84M
Accumulated Expenses (Quarter)	8.34M	3.47M	4.34M	1.94M	10.52M	4.00M	24.28M	10.63M	10.63M	21.83M		18.11M	17.52M	11.60M	60.10M	55.98M	21.20M	18.40M	24.35M	14.70M
Other Accumulated Expenses (Quarter)	0.29M	0.19M	1.70M	1.89M	3.17M	3.19M	0.60M	0.70M	0.53M	0.77M	0.89M	1.08M	0.22M	0.21M	0.42M	0.58M	0.62M	0.59M	0.72M	1.27M
Short term Debt (Quarter)	7.03M	9.49M	0.19M	3.57M	7.21M										12.12M
Current Leases (Quarter)	0.40M	0.37M	0.36M	0.33M	0.30M	0.47M	0.43M	0.45M	0.96M	0.99M	1.03M	1.04M	0.98M	0.84M	0.47M	0.38M	0.34M	0.33M	0.47M	0.49M
Current Deferred Revenue (Quarter)	1.52M	12.40M
Total Current Liabilities (Quarter)	24.29M	28.71M	20.68M	30.55M	30.93M	20.80M	29.07M	23.72M	30.17M	39.17M	58.10M	50.80M	42.47M	59.38M	103.55M	94.55M	112.99M	114.19M	120.12M	86.17M
Non-Current Liabilities
Non-Current Debt (Quarter)	13.32M	10.99M	19.89M	16.48M	12.99M										331.56M
Non-Current Deffered Revenue (Quarter)	10.86M
Preferred Stock Liabilities (Quarter)
Operating Leases (Quarter)	0.02M	0.80M	0.71M	0.64M	0.57M	0.77M	0.71M	0.59M	1.11M	0.85M	0.58M	0.33M	0.13M		2.05M				1.52M
Other Non-Current Liabilities (Quarter)
Total Non-Current Liabilities (Quarter)	24.20M	11.79M	20.61M	17.12M	13.57M	0.78M	0.72M	0.60M	1.13M	0.86M	0.59M	0.33M	0.14M	0.00M	333.14M	331.10M	325.74M	322.18M	344.96M	344.87M
Total Liabilities (Quarter)	48.50M	40.50M	41.29M	47.67M	44.50M	21.59M	29.79M	24.32M	31.30M	40.04M	58.68M	51.14M	42.61M	59.38M	436.69M	425.65M	438.73M	436.36M	465.08M	431.05M
Shareholder's Equity
Total Debt (Quarter)	20.35M	20.48M	20.08M	20.05M	20.21M										343.68M
Common Equity (Quarter)	214.56M	199.00M	408.37M	374.55M	361.94M	338.10M	467.45M	435.50M	400.04M	359.19M	554.20M	491.89M	434.34M	366.43M	288.12M	215.06M	157.42M	115.43M	64.63M	41.62M
Shareholder's Equity (Quarter)	214.56M	199.00M	408.37M	374.55M	361.94M	338.10M	467.45M	435.50M	400.04M	359.19M	554.20M	491.89M	434.34M	366.43M	288.12M	215.06M	157.42M	115.43M	64.63M	41.62M
Liabilities and Shareholders Equity (Quarter)	263.06M	239.50M	449.66M	422.22M	406.44M	359.69M	497.24M	459.83M	431.34M	399.22M	612.88M	543.03M	476.95M	425.81M	724.82M	640.71M	596.15M	551.79M	529.71M	472.67M
Retained Earnings (Quarter)	-619.26M	-639.90M	-543.70M	-580.87M	-618.44M	-653.85M	-693.04M	-734.17M	-778.78M	-829.93M	-902.40M	-974.80M	-1042.86M	-1126.99M	-1221.16M	-1306.00M	-1377.85M	-1438.57M	-1506.58M	-1549.25M
Treasury Shares (Quarter)			0.13M	0.26M	0.26M	0.23M	0.22M	0.39M	0.53M	0.52M	0.52M				1.30M				2.62M

Research Tools

Syndax Pharmaceuticals Balance Sheet (2015-2026) | SNDX

Create an account

Sign In

Reset Password